Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PHASE I TRIAL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1190 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McGinn, CJ; Zalupski, MM
      Combined-modality therapy in pancreatic cancer: Current status and future directions

      CANCER JOURNAL
    2. van de Wijgert, J; Fullem, A; Kelly, C; Mehendale, S; Rugpao, S; Kumwenda, N; Chirenje, Z; Joshi, S; Taha, T; Padian, N; Bollinger, R; Nelson, K
      Phase 1 trial of the topical microbicide BufferGel: Safety results from four international sites

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Sawai, N; Zhou, S; Vanin, EF; Houghton, P; Brent, TP; Sorrentino, BP
      Protection and in vivo selection of hematopoietic stem cells using temozolomide, O-6-benzylguanine, and an alkyltransferase-expressing retroviral vector

      MOLECULAR THERAPY
    4. June, CH
      Can't get any help? New approaches for adoptive immunotherapy of cancer

      JOURNAL OF IMMUNOTHERAPY
    5. Bodell, WJ; Giannini, DD; Hassenbusch, S; Levin, VA
      Levels of N7-(2-hydroxyethyl)guanine as a molecular dosimeter of drug delivery to human brain tumors

      NEURO-ONCOLOGY
    6. Gunzburg, WH; Salmons, B
      Novel clinical strategies for the treatment of pancreatic carcinoma

      TRENDS IN MOLECULAR MEDICINE
    7. Brinkmann, U; Keppler-Hafkemeyer, A; Hafkemeyer, P
      Recombinant immunotoxins for cancer therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    8. Alavi, JB; Eck, SL
      Gene therapy for high grade gliomas

      EXPERT OPINION ON BIOLOGICAL THERAPY
    9. O'Hagan, DT; MacKichan, ML; Singh, M
      Recent developments in adjuvants for vaccines against infectious diseases

      BIOMOLECULAR ENGINEERING
    10. Frenkel, GD; Caffrey, PB
      A prevention strategy for circumventing drug resistance in cancer chemotherapy

      CURRENT PHARMACEUTICAL DESIGN
    11. Johnson, PWM
      The therapeutic use of antibodies for malignancy

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    12. Frankel, AE; Schuster, MW; Jurcic, JG
      Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia

      BIODRUGS
    13. Coze, C; Leimig, T; Jimeno, MT; Mannoni, P
      Retrovirus-mediated gene transfer of the cytokine genes interleukin-1 betaand tumor necrosis factor-alpha into human neuroblastoma cells: consequences for cell line behavior and immunomodulatory properties

      EUROPEAN CYTOKINE NETWORK
    14. Dalakas, MC
      Peripheral neuropathy and antiretroviral drugs

      JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
    15. Buchsbaum, DJ; Curiel, DT
      Gene therapy for the treatment of cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    16. Crombet, T; Torres, O; Neninger, E; Catala, M; Rodriguez, N; Ramos, M; Fernandez, E; Iznaga, N; Perez, R; Lage, A
      Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    17. Margolin, K; Synold, T; Longmate, J; Doroshow, JH
      Methodologic guidelines for the design of high-dose chemotherapy regimens

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    18. Khan, SA; Gaa, B; Pollock, BH; Shea, B; Reddy, V; Wingard, YR; Moreb, JS
      Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    19. Friedberg, JW; Neuberg, D; Monson, J; Jallow, H; Nadler, LM; Freedman, AS
      The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    20. Somlo, G; Chow, W; Hamasaki, V; Leong, L; Margolin, K; Morgan, R; Sniecinski, I; Frankel, P; Reardon, D; Longmate, J; Raschko, J; Shibata, S; O'Donnell, M; Smith, E; Tetef, M; Forman, S; Yen, Y; Molina, A; Doroshow, JH
      Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    21. Kirn, D; Martuza, RL; Zwiebel, J
      Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

      NATURE MEDICINE
    22. Anderson, CP; Seeger, RC; Satake, N; Monforte-Munoz, HL; Keshelava, N; Bailey, HH; Reynolds, CP
      Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    23. Dillman, RO
      Monoclonal antibody therapy for lymphoma - An update

      CANCER PRACTICE
    24. Sereti, I; Lane, HC
      Immunopathogenesis of human immunodeficiency virus: Implications for immune-based therapies

      CLINICAL INFECTIOUS DISEASES
    25. McGinn, CJ; Lawrence, TS
      Recent advances in the use of radio sensitizing nucleosides

      SEMINARS IN RADIATION ONCOLOGY
    26. Berry, SE; Kinsella, TJ
      Targeting DNA mismatch repair for radiosensitization

      SEMINARS IN RADIATION ONCOLOGY
    27. Chmura, SJ; Gupta, N; Advani, SJ; Kufe, DW; Weichselbaum, RR
      Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation

      SEMINARS IN RADIATION ONCOLOGY
    28. Imperiale, MJ; Pass, HI; Sanda, MG
      Prospects for an SV40 vaccine

      SEMINARS IN CANCER BIOLOGY
    29. Kianmanesh, A; Hackett, NR; Lee, JM; Kikuchi, T; Korst, RJ; Crystal, RG
      Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity

      HUMAN GENE THERAPY
    30. Flaherty, KT; Stevenson, JP; O'Dwyer, PJ
      Antisense therapeutics: lessons from early clinical trials

      CURRENT OPINION IN ONCOLOGY
    31. Reff, ME; Heard, C
      A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    32. Goldenberg, DM
      The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    33. DeNardo, GL; Juweid, ME; White, CA; Wiseman, GA; DeNardo, SJ
      Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    34. Calderoni, A; Cerny, T
      Taxanes in lung cancer: a review with focus on the European experience

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    35. Shimizu, Y; Utsugi, K; Umezawa, S; Shimizu, K; Hasumi, K; Suzuki, M; Takaku, F
      Effect of human urinary macrophage colony-stimulating factor on the immunefunctions and the blood cell counts in patients with ovarian carcinoma receiving cytotoxic chemotherapy

      ONCOLOGY REPORTS
    36. Farmer, JP; Montes, JL; Freeman, CR; Meagher-Villemure, K; Bond, MC; O'Gorman, AM
      Brainstem gliomas - A 10-year institutional review

      PEDIATRIC NEUROSURGERY
    37. Mulvihlll, S; Warren, R; Venook, A; Adler, A; Randlev, B; Heise, C; Kirn, D
      Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

      GENE THERAPY
    38. Antczak, C; Bauvois, B; Monneret, C; Florent, JC
      A new acivicin prodrug designed for tumor-targeted delivery

      BIOORGANIC & MEDICINAL CHEMISTRY
    39. Antman, KH
      A critique of the eleven randomised trials of high-dose chemotherapy for breast cancer

      EUROPEAN JOURNAL OF CANCER
    40. Brandes, AA; Lacombe, D; Vecht, C
      Future trends in the treatment of brain tumours

      EUROPEAN JOURNAL OF CANCER
    41. Hoff, PM; Saad, ED; Ravandi-Kashani, F; Czerny, E; Pazdur, R
      Phase I trial of i.v. administered tirapazamine plus cyclophosphamide

      ANTI-CANCER DRUGS
    42. Sonneveld, P
      Multidrug resistance in haematological malignancies (Reprinted from Journal of Internal Medicine, vol 247, pg 521-534, 2000)

      JOURNAL OF INTERNAL MEDICINE
    43. Baumhakel, M; Kasel, D; Rao-Schymanski, RA; Bocker, R; Beckurts, KT; Zaigler, M; Barthold, D; Fuhr, U
      Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    44. Maleniak, TC; Darling, JL; Lowenstein, PR; Castro, MG
      Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell deathin primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU

      CANCER GENE THERAPY
    45. Bollard, CM; Heslop, HE; Brenner, MK
      Gene-marking studies of hematopoietic cells

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    46. Kern, W; Beckert, B; Lang, N; Stemmler, J; Beykirch, M; Stein, J; Goecke, E; Waggershauser, T; Braess, J; Schalhorn, A; Hiddemann, W
      Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer

      ANNALS OF ONCOLOGY
    47. Kornblith, AB; Herndon, JE; Zuckerman, E; Godley, PA; Savarese, D; Vogelzang, NJ; Holland, JC
      The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study

      ANNALS OF ONCOLOGY
    48. Tate, J; Olencki, T; Finke, J; Kottke-Marchant, K; Rybicki, LA; Bukowski, RM
      Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: Clinical and laboratory effects

      ANNALS OF ONCOLOGY
    49. Pfreundschuh, M; Hasenclever, D; Loeffler, M; Ehninger, G; Schmitz, N; Kirchner, H; Koch, P; Lathan, B; Rueffer, U; Sextro, M; Franklin, J; Tesch, H; Diehl, V
      Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF

      ANNALS OF ONCOLOGY
    50. Hidalgo, M; Eckhardt, SG
      Matrix metalloproteinase inhibitors: How can we optimize their development?

      ANNALS OF ONCOLOGY
    51. Rothenberg, ML; Kuhn, JG; Schaaf, LJ; Rodriguez, GI; Eckhardt, SG; Villalona-Calero, MA; Rinaldi, DA; Hammond, LA; Hodges, S; Sharma, A; Elfring, GL; Petit, RG; Locker, PK; Miller, LL; von Hoff, DD
      Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

      ANNALS OF ONCOLOGY
    52. Wasserman, TH; Brizel, DM
      The role of amifostine as a radioprotector

      ONCOLOGY-NEW YORK
    53. Bernstein, ML; Reaman, GH; Hirschfeld, S
      Developmental therapeutics in childhood cancer - A perspective from the Children's Oncology Group and the US Food and Drug Administration

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    54. Perentesis, JP; Sievers, EL
      Targeted therapies for high-risk acute myeloid leukemia

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    55. Rousseau, RF; Hirschmann-Jax, C; Takahashi, S; Brenner, MK
      Cancer vaccines

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    56. Pilati, P; Rossi, CR; Mocellin, S; Foletto, M; Scagnet, B; Pasetto, L; Lise, M
      Multimodal treatment of peritoneal carcinomatosis and sarcomatosis

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    57. Flanagan, DL; Gross, R; Jennings, CD; Caywood, BE; Goes, S; Kaplan, AM; Bryson, JS
      Induction of syngeneic graft-versus-host disease in LPS hyporesponsive C3H/HeJ mice

      JOURNAL OF LEUKOCYTE BIOLOGY
    58. Apisarnthanarax, N; Duvic, M
      Cutaneous T-cell lymphoma - New immunomodulators

      DERMATOLOGIC CLINICS
    59. Curtin, JP; Blessing, JA; Webster, KD; Rose, PG; Mayer, AR; Fowler, WC; Malfetano, JH; Alvarez, RD
      Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: A Gynecologic Oncology Group Study

      JOURNAL OF CLINICAL ONCOLOGY
    60. Sunwoo, JB; Herscher, LL; Kroog, GS; Thomas, GR; Ondrey, FG; Duffey, DC; Solomon, BI; Boss, C; Albert, PS; McCullugh, L; Rudy, S; Muir, C; Zhai, S; Figg, WD; Cook, JA; Mitchell, JB; Van Waes, C
      Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer

      JOURNAL OF CLINICAL ONCOLOGY
    61. Kurzrock, R; Cortes, J; Thomas, DA; Jeha, S; Pilat, S; Talpaz, M
      Pilot study of low-dose interleukin-11 in patients with bone marrow failure

      JOURNAL OF CLINICAL ONCOLOGY
    62. Cheson, BD
      Some like it hot!

      JOURNAL OF CLINICAL ONCOLOGY
    63. Lee, P; Wang, F; Kuniyoshi, J; Rubio, V; Stuges, T; Groshen, S; Gee, C; Lau, R; Jeffery, G; Margolin, K; Marty, V; Weber, J
      Effects of interleukin-12 on the immune response to a multipeptide vaccinefor resected metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    64. Regine, WF; Valentino, J; Arnold, SM; Haydon, RC; Sloan, D; Kenady, D; Strottmann, J; Pulmano, C; Mohiuddin, M
      High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck

      JOURNAL OF CLINICAL ONCOLOGY
    65. Kelly, WK; Curley, T; Slovin, S; Heller, G; McCaffrey, J; Bajorin, D; Ciolino, A; Regan, K; Schwartz, M; Kantoff, P; George, D; Oh, W; Smith, M; Kaufman, D; Small, EJ; Schwartz, L; Larson, S; Tong, W; Scher, H
      Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer

      JOURNAL OF CLINICAL ONCOLOGY
    66. Korn, EL; Arbuck, SG; Pluda, JM; Simon, R; Kaplan, RS; Christian, MC
      Clinical trial designs for cytostatic agents: Are new approaches needed?

      JOURNAL OF CLINICAL ONCOLOGY
    67. Saha, S; Mondal, S
      Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    68. Akiyama, Y; Ohe, Y; Tamura, T; Sawada, M; Inoue, A; Kusaba, H; Yamamoto, N; Sekine, I; Kunitoh, H; Kodama, T; Saijo, N
      A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    69. Okada, S; Ueno, H; Okusaka, T; Ikeda, M; Furuse, J; Maru, Y
      Phase I trial of gemcitabine in patients with advanced pancreatic cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    70. Xu, S; Zakian, K; Thaler, H; Matei, C; Alfleri, A; Chen, YC; Koutcher, JA
      Effects of motexafin gadolinium on tumor metabolism and radiation sensitivity

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    71. Kornek, GV; Potter, R; Selzer, E; Schratter, A; Ulrich-Pur, H; Rogy, M; Kraus, G; Scheithauer, W
      Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    72. Mehta, M; Scrimger, R; Mackie, R; Paliwal, B; Chappell, R; Fowler, J
      A new approach to dose escalation in non-small-cell lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    73. Koch, CJ; Hahn, SM; Rockwell, K; Covey, JM; McKenna, WG; Evans, SM
      Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitrolmidazoles

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    74. Edelman, MJ; Quam, H; Mullins, B
      Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    75. Witzig, TE
      Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    76. Fyfe, D; Price, C; Langley, RE; Pagonis, C; Houghton, J; Osborne, L; Woll, PJ; Gardner, C; Baguley, BC; Carmichael, J
      A phase I trial of amsalog (Cl-921) administered by intravenous infusion using a 5-day schedule

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    77. Papadopoulos, KP; Egorin, MJ; Huang, M; Troxel, AB; Kaufman, E; Balmaceda, CM; Vahdat, LT; Hesdorffer, CS
      The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m(2) continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    78. Nakamura, K; Tanaka, Y; Shitara, K; Hanai, N
      Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functions

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    79. Postema, EJ; Boerman, OC; Oyen, WJG; Raemaekers, JMM; Corstens, FHM
      Radioimmunotherapy of B-cell non-Hodgkin's lymphoma

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    80. Tran, JQ; Gerber, LG; Kerr, BM
      Delavirdine - Clinical pharmacokinetics and drug interactions

      CLINICAL PHARMACOKINETICS
    81. Antman, KH
      Randomized trials of high dose chemotherapy for breast cancer

      BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    82. Scott, CL; Robb, L; Nandurkar, HH; Mansfield, R; Alexander, WS; Begley, CG
      Thrombopoietin signaling is required for in vivo expansion of IL-11-responsive hematopoietic progenitor cells in the steady state

      EXPERIMENTAL HEMATOLOGY
    83. Kouroussis, C; Kakolyris, S; Mavroudis, D; Androulakis, N; Kalbakis, K; Agelaki, S; Sarra, E; Souglakos, J; Christodoulakis, M; Samonis, G; Georgoulias, V
      A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    84. Matheny, CJ; Lamb, MW; Brouwer, KLR; Pollack, GM
      Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation

      PHARMACOTHERAPY
    85. Flinn, IW; Lazarus, HM
      Monoclonal antibodies and autologous stem cell transplantation for lymphoma

      BONE MARROW TRANSPLANTATION
    86. Moingeon, P; Haensler, J; Lindberg, A
      Towards the rational design of Th1 adjuvants

      VACCINE
    87. Moingeon, P
      Cancer vaccines

      VACCINE
    88. Ridwelski, K; Meyer, F
      Current options for palliative treatment in patients with pancreatic cancer

      DIGESTIVE DISEASES
    89. Habrand, JL; De Crevoisier, R
      Radiation therapy in the management of childhood brain tumors

      CHILDS NERVOUS SYSTEM
    90. Cheng, AL; Hsu, CH; Lin, JK; Hsu, MM; Ho, YF; Shen, TS; Ko, JY; Lin, JT; Lin, BR; Wu, MS; Yu, HS; Jee, SH; Chen, GS; Chen, TM; Chen, CA; Lai, MK; Pu, YS; Pan, MH; Wang, YJ; Tsai, CC; Hsieh, CY
      Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions

      ANTICANCER RESEARCH
    91. Hsu, CH; Chen, J; Wu, CY; Cheng, AL; Pu, YS
      Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma

      ANTICANCER RESEARCH
    92. Hofer, S; Herrmann, R
      Chemotherapy for malignant brain tumors of astrocytic and oligodendrogliallineage

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    93. Gajra, A; Mehdi, SA; Kirshner, J; Newman, N; Graziano, SL
      Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma

      LUNG CANCER
    94. Phan, TP; Crane, CH; Janjan, NA; Vrdoljak, E; Milas, L; Mason, KA
      WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment

      INTERNATIONAL JOURNAL OF PANCREATOLOGY
    95. Nishikawa, Y; Iwata, A; Katsumata, A; Xuan, XN; Nagasawa, H; Igarashi, I; Fujisaki, K; Otsuka, H; Mikami, T
      Expression of canine interferon-gamma by a recombinant vaccinia virus and its antiviral effect

      VIRUS RESEARCH
    96. van Zuylen, L; Verweij, J; Sparreboom, A
      Role of formulation vehicles in taxane pharmacology

      INVESTIGATIONAL NEW DRUGS
    97. Holst-Hansen, C; Low, JA; Stephens, RW; Johnson, MD; Carmeliet, P; Frandsen, TL; Brunner, N; Dickson, RB
      Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat

      BREAST CANCER RESEARCH AND TREATMENT
    98. Kintzel, PE
      Anticancer drug-induced kidney disorders - Incidence, prevention and management

      DRUG SAFETY
    99. Tan, AR; Swain, SM
      Novel agents: Clinical trial design

      SEMINARS IN ONCOLOGY
    100. Oh, WK; George, DJ; Kaufman, DS; Moss, K; Smith, MR; Richie, JP; Kantoff, PW
      Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: A preliminary report

      SEMINARS IN ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 15:33:23